LY22-02g

Main Content

Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T-cell therapy: A CIBMTR analysis.

Study #: LY22-02g

Study Status: Published

Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T-cell therapy: A CIBMTR analysis.

Citation

Epperla N, Hashmi H, Ahn KW, Chen AI, Wirk B, Kanakry JA, Lekakis L, Lekakis L, Kharfan-Dabaja MA, Scordo M, Riedell PA, Jain T, Shadman M, Sauter C, Hamadani M, Herrera AF, Ahmed S.

British Journal of Haematology. 2024, Sep 01: 205(3): 205(3):1202-1207. doi: 10.1111/bjh.19569. Epub 2024, May 26. PMCID:PMC11499028.

PubMed

PMID: 38797526

Abstract